244 related articles for article (PubMed ID: 34443529)
1. Bee Venom: From Venom to Drug.
Khalil A; Elesawy BH; Ali TM; Ahmed OM
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443529
[TBL] [Abstract][Full Text] [Related]
2. Bee venom therapy: Potential mechanisms and therapeutic applications.
Zhang S; Liu Y; Ye Y; Wang XR; Lin LT; Xiao LY; Zhou P; Shi GX; Liu CZ
Toxicon; 2018 Jun; 148():64-73. PubMed ID: 29654868
[TBL] [Abstract][Full Text] [Related]
3. Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests.
Wehbe R; Frangieh J; Rima M; El Obeid D; Sabatier JM; Fajloun Z
Molecules; 2019 Aug; 24(16):. PubMed ID: 31430861
[TBL] [Abstract][Full Text] [Related]
4. Vitellogenins are new high molecular weight components and allergens (Api m 12 and Ves v 6) of Apis mellifera and Vespula vulgaris venom.
Blank S; Seismann H; McIntyre M; Ollert M; Wolf S; Bantleon FI; Spillner E
PLoS One; 2013; 8(4):e62009. PubMed ID: 23626765
[TBL] [Abstract][Full Text] [Related]
5.
Zheng X; Liu Y; Wang R; Geng M; Liu J; Liu Z; Zhao Y
Arch Insect Biochem Physiol; 2024 Mar; 115(3):e22104. PubMed ID: 38506277
[TBL] [Abstract][Full Text] [Related]
6. Human scFv antibodies (Afribumabs) against Africanized bee venom: Advances in melittin recognition.
Pessenda G; Silva LC; Campos LB; Pacello EM; Pucca MB; Martinez EZ; Barbosa JE
Toxicon; 2016 Mar; 112():59-67. PubMed ID: 26829652
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase A2-induced coagulation abnormalities after bee sting.
Petroianu G; Liu J; Helfrich U; Maleck W; Rüfer R
Am J Emerg Med; 2000 Jan; 18(1):22-7. PubMed ID: 10674526
[TBL] [Abstract][Full Text] [Related]
8. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
Ruiz B; Serrano P; Moreno C
J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
[TBL] [Abstract][Full Text] [Related]
9. [Honey bee venom allergy diagnostics].
Dyga W; Stobiecki M; Czarnobilska E
Przegl Lek; 2016; 73(12):838-41. PubMed ID: 29693991
[TBL] [Abstract][Full Text] [Related]
10. Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3.
Blank S; Seismann H; Bockisch B; Braren I; Cifuentes L; McIntyre M; Rühl D; Ring J; Bredehorst R; Ollert MW; Grunwald T; Spillner E
J Immunol; 2010 May; 184(9):5403-13. PubMed ID: 20348419
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Properties of
El-Seedi H; Abd El-Wahed A; Yosri N; Musharraf SG; Chen L; Moustafa M; Zou X; Al-Mousawi S; Guo Z; Khatib A; Khalifa S
Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32664544
[TBL] [Abstract][Full Text] [Related]
12. Honeybee venom proteome profile of queens and winter bees as determined by a mass spectrometric approach.
Danneels EL; Van Vaerenbergh M; Debyser G; Devreese B; de Graaf DC
Toxins (Basel); 2015 Oct; 7(11):4468-83. PubMed ID: 26529016
[TBL] [Abstract][Full Text] [Related]
13. Allergens in Hymenoptera venom. XXVII: bumblebee venom allergy and allergens.
Hoffman DR; Jacobson RS
J Allergy Clin Immunol; 1996 Mar; 97(3):812-21. PubMed ID: 8613638
[TBL] [Abstract][Full Text] [Related]
14. Bee venom immunotherapy and bee-sting mortality in Australia.
Ford RM
Med J Aust; 1984 Apr; 140(9):563-4. PubMed ID: 6708906
[No Abstract] [Full Text] [Related]
15. Bee Venom Components as Therapeutic Tools against Prostate Cancer.
Badawi JK
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34067049
[TBL] [Abstract][Full Text] [Related]
16. Component resolution reveals additional major allergens in patients with honeybee venom allergy.
Köhler J; Blank S; Müller S; Bantleon F; Frick M; Huss-Marp J; Lidholm J; Spillner E; Jakob T
J Allergy Clin Immunol; 2014 May; 133(5):1383-9, 1389.e1-6. PubMed ID: 24440283
[TBL] [Abstract][Full Text] [Related]
17. Structure and biology of stinging insect venom allergens.
King TP; Spangfort MD
Int Arch Allergy Immunol; 2000 Oct; 123(2):99-106. PubMed ID: 11060481
[TBL] [Abstract][Full Text] [Related]
18. Bee venom: apitherapy and more.
Jodidio M; Schwartz RA
Ital J Dermatol Venerol; 2024 Feb; 159(1):4-10. PubMed ID: 37997319
[TBL] [Abstract][Full Text] [Related]
19. Biochemical variability of venoms from individual European and Africanized honeybees (Apis mellifera).
Schumacher MJ; Schmidt JO; Egen NB; Dillon KA
J Allergy Clin Immunol; 1992 Jul; 90(1):59-65. PubMed ID: 1629508
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
